Life ScienceCompany
Blueprint Medicines M&A Summary
Blueprint Medicines has acquired 1 company, including 1 in the last 5 years.
Blueprint Medicines’ largest acquisition to date was in 2021, when it acquired Lengo Therapeutics for $250M. Blueprint Medicines has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Blueprint Medicines Business Overview
Where is Blueprint Medicines headquartered?
Blueprint Medicines is headquartered in Cambridge, Massachusetts.
What is Blueprint Medicines’ revenue?
Blueprint Medicines disclosed revenue of 249M USD for 2023 and 204M USD for 2022.
How many employees does Blueprint Medicines have?
Blueprint Medicines has 638 employees.
What sector is Blueprint Medicines in?
Blueprint Medicines is a life science company.
When was Blueprint Medicines founded?
Blueprint Medicines was founded in 2008.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2
Unlimited Searches
